(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 0.68 | 0.36 | 88.89 | 2.76 | 0.59 | 367.80 | 3.65 | 69.91 | -94.78 |
| Other Income | 4.32 | 4.27 | 1.17 | 8.73 | 8.05 | 8.45 | 19.19 | 14.66 | 30.90 |
| PBIDT | 2.28 | 2.02 | 12.87 | 5.16 | 3.03 | 70.30 | 10.25 | 23.12 | -55.67 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 2.28 | 2.02 | 12.87 | 5.16 | 3.03 | 70.30 | 10.25 | 23.12 | -55.67 |
| Depreciation | 0.23 | 0.18 | 27.78 | 0.46 | 0.32 | 43.75 | 0.92 | 0.58 | 58.62 |
| PBT | 2.05 | 1.84 | 11.41 | 4.70 | 2.71 | 73.43 | 9.33 | 22.54 | -58.61 |
| TAX | 0.70 | 0.00 | 0.00 | 1.40 | 0.00 | 0.00 | 4.57 | 8.05 | -43.23 |
| Deferred Tax | -0.30 | 0.00 | 0.00 | 0.40 | 0.00 | 0.00 | 0.22 | 4.48 | -95.09 |
| PAT | 1.35 | 1.84 | -26.63 | 3.30 | 2.71 | 21.77 | 4.76 | 14.49 | -67.15 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 335.29 | 561.11 | -40.24 | 186.96 | 513.56 | -63.60 | 280.82 | 33.07 | 749.15 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: